Currently, wet macular degeneration (wAMD) is the only form of AMD that is treatable, usually involving the use of vascular endothelial growth factor inhibitors (anti-VEGF) such as ranibizumab, aflibercept, or bevacizumab [3]. Here, VEGFA is linked to wet macular degeneration.